Met in Urological Cancers

Met in Urological Cancers

Met is a tyrosine kinase receptor that is considered to be a proto-oncogene. The hepatocyte growth factor (HGF)-Met signaling system plays an important role in tumor growth, invasion, and metastasis in many types of malignancies. Furthermore, Met expression has been reported to be a useful predicti...

Full description

Bibliographic Details
Main Authors: Yasuyoshi Miyata, Akihiro Asai, Kensuke Mitsunari, Tomohiro Matsuo, Kojiro Ohba, Yasushi Mochizuki, Hideki Sakai
Format: Article
Language:English
Published: MDPI AG 2014-12-01
Series:Cancers
Subjects:
Met
prostate cancer
renal cell carcinoma
urothelial cancer
pathological features
survival
target therapy
Online Access:http://www.mdpi.com/2072-6694/6/4/2387

Internet

http://www.mdpi.com/2072-6694/6/4/2387

Similar Items